Foncer Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-12-2024
- Paid Up Capital ₹ 1.00 M
as on 08-12-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.80 Cr
as on 08-12-2024
- Satisfied Charges ₹ 1.51 Cr
as on 08-12-2024
- Revenue 30.14%
(FY 2021)
- Profit 103.59%
(FY 2021)
- Ebitda -69.82%
(FY 2021)
- Net Worth 84.88%
(FY 2021)
- Total Assets 51.66%
(FY 2021)
About Foncer Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.80 Cr. The company has closed loans amounting to ₹1.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Swapnilkumar Deotalu and Parag Kumbalkar serve as directors at the Company.
- CIN/LLPIN
U74999MH2016PTC283986
- Company No.
283986
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Foncer Pharma Private Limited offer?
Foncer Pharma Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Cholesterol Medicine, Diabetes Medicine, Kidney Drugs, Antianginal Drugs.
Who are the key members and board of directors at Foncer Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parag Kumbalkar  | Additional Director | 30-Apr-2019 | Current |
| Swapnilkumar Deotalu | Director | 11-May-2018 | Current |
Financial Performance of Foncer Pharma.
Foncer Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 30.14% increase. The company also saw a substantial improvement in profitability, with a 103.59% increase in profit. The company's net worth Soared by an impressive increase of 84.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Foncer Pharma?
In 2022, Foncer Pharma had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Foncer Wellness Private LimitedActive 1 month 27 daysSwapnilkumar Deotalu and Parag Kumbalkar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Sep 2023 | ₹1.80 Cr | Open |
Others Creation Date: 13 Mar 2023 | ₹1.20 Cr | Satisfied |
Canara Bank Creation Date: 17 Jun 2020 | ₹0.30 M | Satisfied |
How Many Employees Work at Foncer Pharma?
Foncer Pharma has a workforce of 38 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Foncer Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Foncer Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
